meitshel

EVAX - risky AI - biotech low floater

meitshel 업데이트됨   
NASDAQ:EVAX   Evaxion Biotech A/S
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

This is not a financial advice!

Upcoming catalysts on 09/30 2024 and 12/31/2024

Shs. Float of 2.91M

This could be a slower play. Don't expect a fast move. But i see lots of potential in this company.

We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.

Keep an eye on 5.3/ 5.7/ 7.0 levels, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.

SL under 2.5

TPs approx. 9.0 or even 13

Most info on the chart.

Trade carefully!
코멘트:
Evaxion: An Intriguing AI Vaccine Company With Big Pharma Collaboration
코멘트:
Ladenburg Thalmann Upgrades Evaxion Biotech to Buy, Announces $8 Price Target
면책사항

이 정보와 게시물은 TradingView에서 제공하거나 보증하는 금융, 투자, 거래 또는 기타 유형의 조언이나 권고 사항을 의미하거나 구성하지 않습니다. 자세한 내용은 이용 약관을 참고하세요.